Backed by extensive industry expertise, the fund manager has successfully executed over 30 investments across the biotechnology and digital health sectors. Engaged primarily in early to growth-stage opportunities, they emphasize a data-driven approach that leverages strategic insights to identify promising innovations. The manager's portfolio features notable exits that highlight a commitment to operational excellence and value creation in the healthcare landscape. Active in both North American and European markets, the team employs a thematic investment strategy, targeting trends that promise transformative impacts on patient care.